Abstract
Emerald Vieira, Emmanuel Kwadwo Awuttey, Kwaku Amponsah Obeng, Anastasia Naa Koshie Bruce, Charles Frederick Hayfron-Benjamin
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches
10.1097/coh.0000000000000923 · 2025
Neuroinflammation, blood–Brain barrier, and HIV reservoirs in the CNS: an In-depth exploration of latency mechanisms and emerging therapeutic strategies
10.3390/v17040572 · 2025
HIV-related neurocognitive disorders: diagnosis, treatment, and mental health implications: a review
10.1097/md.0000000000035652 · 2023
Update on neurological complications of HIV
10.1097/coh.0000000000000951 · 2025
Autonomic neuropathy in HIV is unrecognized and associated with medical morbidity
10.1089/apc.2013.0188 · 2013
Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction?
10.1186/1741-7015-9-138 · 2011
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
10.1212/wnl.0000000000000492 · 2014
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
openalex
Confidence 95%
datacite
Confidence 0%
Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period
10.1097/qad.0000000000002709 · 2021
Neurologic presentations of AIDS
10.1016/j.ncl.2009.09.018 · 2010
CNS neurotoxicity of antiretrovirals
10.1007/s11481-019-09886-7 · 2021
The role of nutrition in HIV-associated neurocognitive disorders: mechanisms, risks, and interventions
10.3390/life15060982 · 2025
Unresolved referenced work
2017
Functional neuroimaging in clinical neurology: a comprehensive review of commonly used modalities
10.1055/a-2773-5481 · 2025
Neurophysiology in clinical practice
2004
Molecular biomarkers in neurological diseases: advances in diagnosis and prognosis
10.3390/ijms26052231 · 2025
Deep phenotyping for precision medicine
10.1002/humu.22080 · 2012
Digital phenotyping in clinical neurology
10.1055/s-0041-1741495 · 2022
Underrepresentation of Africa in HIV cure research: a systematic review of the literature from 2010 to 2022
2026
The global HIV metabolome cannot be defined without Africa
10.1016/j.lanafr.2026.100142 · 2026
Assessment of neurocognitive deficits in people living with HIV in Sub Saharan Africa: a systematic review
10.1080/13854046.2019.1606284 · 2019
Neurological disorders in HIV in Africa: a review
10.4314/ahs.v19i2.19 · 2019
Prevalence and variability of HIV/AIDS-associated neurocognitive impairments in Africa: a systematic review and meta-analysis
10.1186/s12889-023-15935-x · 2023
Dysregulated metabolism in people living with HIV in the modern ART-era: a systematic review of targeted metabolomics studies
10.1002/rmv.70179 · 2026
P-1406. Racial disparities in HIV prevalence and complications in hospitalized patients
2025
Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy
10.1016/j.jpainsymman.2008.08.007 · 2009
The relationship between race and HIV-distal sensory polyneuropathy in a large cohort of US women
10.1016/j.jns.2011.11.009 · 2012
The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study
10.1097/qai.0b013e3181adcefa · 2009
Racial differences in clinical presentation in individuals diagnosed with frontotemporal dementia
10.1001/jamaneurol.2023.3093 · 2023
Racial differences in neuromyelitis Optica spectrum disorder
10.1212/wnl.0000000000006574 · 2018
Ethnic/racial disparities in longitudinal neurocognitive decline in people with HIV
10.1097/qai.0000000000002922 · 2022
Ethnic/racial disparities in longitudinal neurocognitive decline in people with HIV
10.1097/qai.0000000000002922 · 2022
High-depth African genomes inform human migration and health
10.1038/s41586-020-2859-7 · 2020
African genetic diversity provides novel insights into evolutionary history and local adaptations
10.1093/hmg/ddy161 · 2018
Rapid diagnostic tests for neurological infections in central Africa
10.1016/s1473-3099(13)70004-5 · 2013
Vascular phenotyping in diabetes research in sub-saharan Africa: a neglected priority with high translational value
10.1016/j.deman.2026.100303 · 2026
Strengthening pulmonary function testing capacity in Sub-Saharan Africa
10.1016/j.chest.2025.12.021 · 2026
H3Africa: a model for implementing biobank-based genomic research in resource-constrained settings
10.1093/hmg/ddaf113 · 2025
H3Africa: a model for implementing biobank-based genomic research in resource-constrained settings
10.1093/hmg/ddaf113 · doi-reference
Strengthening pulmonary function testing capacity in Sub-Saharan Africa
10.1016/j.chest.2025.12.021 · doi-reference
Vascular phenotyping in diabetes research in sub-saharan Africa: a neglected priority with high translational value
10.1016/j.deman.2026.100303 · doi-reference
Rapid diagnostic tests for neurological infections in central Africa
10.1016/s1473-3099(13)70004-5 · doi-reference
African genetic diversity provides novel insights into evolutionary history and local adaptations
10.1093/hmg/ddy161 · doi-reference
High-depth African genomes inform human migration and health
10.1038/s41586-020-2859-7 · doi-reference
Ethnic/racial disparities in longitudinal neurocognitive decline in people with HIV
10.1097/qai.0000000000002922 · doi-reference
Racial differences in neuromyelitis Optica spectrum disorder
10.1212/wnl.0000000000006574 · doi-reference
Racial differences in clinical presentation in individuals diagnosed with frontotemporal dementia
10.1001/jamaneurol.2023.3093 · doi-reference
The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study
10.1097/qai.0b013e3181adcefa · doi-reference
The relationship between race and HIV-distal sensory polyneuropathy in a large cohort of US women
10.1016/j.jns.2011.11.009 · doi-reference
Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy
10.1016/j.jpainsymman.2008.08.007 · doi-reference
Dysregulated metabolism in people living with HIV in the modern ART-era: a systematic review of targeted metabolomics studies
10.1002/rmv.70179 · doi-reference
Prevalence and variability of HIV/AIDS-associated neurocognitive impairments in Africa: a systematic review and meta-analysis
10.1186/s12889-023-15935-x · doi-reference
Neurological disorders in HIV in Africa: a review
10.4314/ahs.v19i2.19 · doi-reference
Assessment of neurocognitive deficits in people living with HIV in Sub Saharan Africa: a systematic review
10.1080/13854046.2019.1606284 · doi-reference
The global HIV metabolome cannot be defined without Africa
10.1016/j.lanafr.2026.100142 · doi-reference
Digital phenotyping in clinical neurology
10.1055/s-0041-1741495 · doi-reference
Deep phenotyping for precision medicine
10.1002/humu.22080 · doi-reference
Molecular biomarkers in neurological diseases: advances in diagnosis and prognosis
10.3390/ijms26052231 · doi-reference
Functional neuroimaging in clinical neurology: a comprehensive review of commonly used modalities
10.1055/a-2773-5481 · doi-reference
The role of nutrition in HIV-associated neurocognitive disorders: mechanisms, risks, and interventions
10.3390/life15060982 · doi-reference
CNS neurotoxicity of antiretrovirals
10.1007/s11481-019-09886-7 · doi-reference
Neurologic presentations of AIDS
10.1016/j.ncl.2009.09.018 · doi-reference
Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period
10.1097/qad.0000000000002709 · doi-reference
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
10.1212/wnl.0000000000000492 · doi-reference
Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction?
10.1186/1741-7015-9-138 · doi-reference
Autonomic neuropathy in HIV is unrecognized and associated with medical morbidity
10.1089/apc.2013.0188 · doi-reference
Update on neurological complications of HIV
10.1097/coh.0000000000000951 · doi-reference
HIV-related neurocognitive disorders: diagnosis, treatment, and mental health implications: a review
10.1097/md.0000000000035652 · doi-reference
Neuroinflammation, blood–Brain barrier, and HIV reservoirs in the CNS: an In-depth exploration of latency mechanisms and emerging therapeutic strategies
10.3390/v17040572 · doi-reference
Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches
10.1097/coh.0000000000000923 · doi-reference